Apriem Advisors decreased its stake in Exxon Mobil Corp (XOM) by 4.78% based on its latest 2017Q4 regulatory filing with the SEC. Apriem Advisors sold 7,925 shares as the company’s stock declined 12.23% with the market. The institutional investor held 157,997 shares of the integrated oil company at the end of 2017Q4, valued at $13.22M, down from 165,922 at the end of the previous reported quarter. Apriem Advisors who had been investing in Exxon Mobil Corp for a number of months, seems to be less bullish one the $347.51B market cap company. The stock increased 0.96% or $0.78 during the last trading session, reaching $82.08. About 5.15 million shares traded. Exxon Mobil Corporation (NYSE:XOM) has declined 9.29% since May 21, 2017 and is downtrending. It has underperformed by 20.84% the S&P500.
Jlb & Associates Inc increased its stake in Abbvie (ABBV) by 7.07% based on its latest 2017Q4 regulatory filing with the SEC. Jlb & Associates Inc bought 4,643 shares as the company’s stock declined 6.31% with the market. The institutional investor held 70,277 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $6.80 million, up from 65,634 at the end of the previous reported quarter. Jlb & Associates Inc who had been investing in Abbvie for a number of months, seems to be bullish on the $169.10 billion market cap company. The stock increased 0.55% or $0.58 during the last trading session, reaching $106.56. About 3.44 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 39.20% since May 21, 2017 and is uptrending. It has outperformed by 27.65% the S&P500.
Investors sentiment decreased to 0.84 in 2017 Q4. Its down 0.01, from 0.85 in 2017Q3. It is negative, as 48 investors sold XOM shares while 819 reduced holdings. 123 funds opened positions while 603 raised stakes. 2.17 billion shares or 1.92% more from 2.13 billion shares in 2017Q3 were reported. Cambridge Investment Advsr invested in 0.61% or 621,107 shares. Terril Brothers invested 0.29% in Exxon Mobil Corporation (NYSE:XOM). Oarsman Cap reported 0.47% stake. 202,919 are owned by Cetera Advsrs Limited Co. Bancshares Of The West stated it has 45,670 shares or 0.48% of all its holdings. Beech Hill Advsr has invested 2.15% in Exxon Mobil Corporation (NYSE:XOM). Oregon Employees Retirement Fund reported 0.6% of its portfolio in Exxon Mobil Corporation (NYSE:XOM). Moreover, Ct Mason has 0.67% invested in Exxon Mobil Corporation (NYSE:XOM). Triangle Securities Wealth Mgmt holds 51,953 shares. Winslow Evans & Crocker reported 94,544 shares or 2.54% of all its holdings. Maple Cap has invested 1.18% of its portfolio in Exxon Mobil Corporation (NYSE:XOM). Motco reported 126,376 shares. Cullinan Assoc holds 410,527 shares or 2.52% of its portfolio. Elm Advsrs Llc holds 0.18% of its portfolio in Exxon Mobil Corporation (NYSE:XOM) for 2,880 shares. Botty Invsts Lc has invested 0.26% in Exxon Mobil Corporation (NYSE:XOM).
Apriem Advisors, which manages about $424.33M and $403.51 million US Long portfolio, upped its stake in Pimco Invest Grade Corp by 4,075 shares to 9,482 shares, valued at $1.00 million in 2017Q4, according to the filing. It also increased its holding in Vanguard Internatnl Hgh by 6,010 shares in the quarter, for a total of 94,960 shares, and has risen its stake in Schwab Emerging Markets (SCHE).
Analysts await Exxon Mobil Corporation (NYSE:XOM) to report earnings on July, 27. They expect $1.16 earnings per share, up 48.72% or $0.38 from last year’s $0.78 per share. XOM’s profit will be $4.91B for 17.69 P/E if the $1.16 EPS becomes a reality. After $1.09 actual earnings per share reported by Exxon Mobil Corporation for the previous quarter, Wall Street now forecasts 6.42% EPS growth.
Since December 11, 2017, it had 0 insider purchases, and 4 insider sales for $3.42 million activity. Wascom Dennis G sold $200,293 worth of stock. The insider Corson Bradley W sold 19,500 shares worth $1.62M. Shares for $996,628 were sold by Chapman Neil A.
Among 26 analysts covering Exxon Mobil (NYSE:XOM), 10 have Buy rating, 5 Sell and 11 Hold. Therefore 38% are positive. Exxon Mobil had 95 analyst reports since July 22, 2015 according to SRatingsIntel. The firm earned “Underperform” rating on Wednesday, November 18 by Raymond James. The rating was downgraded by Wells Fargo on Wednesday, January 11 to “Market Perform”. The firm earned “Buy” rating on Thursday, May 11 by Bank of America. The rating was maintained by Piper Jaffray on Sunday, April 22 with “Hold”. The firm earned “Overweight” rating on Tuesday, October 10 by Barclays Capital. The firm has “Hold” rating by Piper Jaffray given on Thursday, October 5. The stock of Exxon Mobil Corporation (NYSE:XOM) has “Hold” rating given on Thursday, April 19 by Jefferies. The rating was maintained by Credit Suisse with “Neutral” on Monday, April 30. The company was maintained on Monday, June 26 by BMO Capital Markets. As per Tuesday, January 26, the company rating was downgraded by Tudor Pickering.
More notable recent Exxon Mobil Corporation (NYSE:XOM) news were published by: Seekingalpha.com which released: “Reuters: Exxon’s Baytown refinery gasoline unit shut” on May 11, 2018, also Livetradingnews.com with their article: “Exxon Mobil Corporation (NYSE:XOM) Extending Gains” published on May 10, 2018, Seekingalpha.com published: “Reuters: Exxon’s Beaumont refinery to overhaul coker, hydrotreater” on May 14, 2018. More interesting news about Exxon Mobil Corporation (NYSE:XOM) were released by: Seekingalpha.com and their article: “Exxon Mobil’s Fair Value Is $78 Per Share” published on May 14, 2018 as well as Seekingalpha.com‘s news article titled: “Exxon: Irrational Exuberance” with publication date: May 11, 2018.
Since December 14, 2017, it had 0 buys, and 11 selling transactions for $47.70 million activity. ALBAN CARLOS had sold 83,574 shares worth $9.57M on Wednesday, February 28. 25,000 shares were sold by Schumacher Laura J, worth $2.95 million on Wednesday, February 28. SALEKI-GERHARDT AZITA sold $157,458 worth of stock or 1,337 shares. The insider CHASE WILLIAM J sold $8.31M. $976,084 worth of AbbVie Inc. (NYSE:ABBV) was sold by GONZALEZ RICHARD A on Wednesday, February 28. 4,294 AbbVie Inc. (NYSE:ABBV) shares with value of $512,853 were sold by Michael Robert A..
Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.05, from 0.85 in 2017Q3. It worsened, as 42 investors sold ABBV shares while 695 reduced holdings. 139 funds opened positions while 448 raised stakes. 1.06 billion shares or 0.35% more from 1.06 billion shares in 2017Q3 were reported. Private Wealth Prtnrs Ltd Llc invested 0.13% of its portfolio in AbbVie Inc. (NYSE:ABBV). Bradley Foster & Sargent Ct holds 0.57% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 163,426 shares. Sigma Planning Corp owns 0.42% invested in AbbVie Inc. (NYSE:ABBV) for 56,438 shares. Fort LP reported 96,912 shares stake. Zeke Cap Advisors Limited Liability Com reported 0.31% in AbbVie Inc. (NYSE:ABBV). Reynders Mcveigh Cap Management Lc reported 39,089 shares or 0.5% of all its holdings. Alethea Cap Management Ltd Com has invested 1.23% in AbbVie Inc. (NYSE:ABBV). First National Bank & Trust Of Omaha has invested 0.11% in AbbVie Inc. (NYSE:ABBV). Fulton Bancorp Na has 0.4% invested in AbbVie Inc. (NYSE:ABBV) for 58,093 shares. Sva Plumb Wealth Mgmt Limited Com holds 0.08% in AbbVie Inc. (NYSE:ABBV) or 6,991 shares. Tower Bridge, a Pennsylvania-based fund reported 35,133 shares. Sadoff Ltd Liability holds 0.05% or 6,673 shares. Northeast Invest Mngmt, Massachusetts-based fund reported 10,033 shares. 3,561 are owned by Fairview Investment Ltd Co. Schmidt P J Invest Mgmt holds 2.1% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 76,866 shares.